SciTransfer
Organization

CHAMBRE DE COMMERCE ET D'INDUSTRIE DE REGION PARIS ILE-DE-FRANCE

Paris regional chamber of commerce delivering Enterprise Europe Network SME innovation services and contributing business ecosystem expertise to diverse EU research consortia.

Public authoritymultidisciplinaryFR
H2020 projects
16
As coordinator
5
Total EC funding
€1.9M
Unique partners
188
What they do

Their core work

CCI Paris Ile-de-France is the regional chamber of commerce serving the greater Paris area — one of the largest CCIs in Europe, representing hundreds of thousands of businesses. Within H2020, their primary role has been operating Enterprise Europe Network (EEN) services: helping SMEs access innovation support, technology transfer, and EU funding instruments. They also contribute business ecosystem expertise to research and technology projects spanning water sensing, manufacturing skills, border security, and health genomics, acting as a bridge between research consortia and the industrial fabric of the Paris region.

Core expertise

What they specialise in

Enterprise Europe Network (EEN) innovation managementprimary
5 projects

Coordinated five consecutive TOPIC2INNO projects (2014-2021) delivering KAM/EIMC innovation management services to SMEs across Ile-de-France and French overseas territories.

SME technology transfer and business supportprimary
6 projects

All EEN projects plus participation in R2PI (circular economy policy) and FIT4FoF (workforce skills) demonstrate consistent focus on translating research outputs into SME-usable services.

Sensor and microelectronics applicationssecondary
3 projects

Participated in PROTEUS (microfluidic water quality sensing), InForMed (micro-fabricated medical devices), and C-BORD (container inspection), contributing business validation or market access.

Research and innovation policy studiessecondary
2 projects

Third-party role in KNOWMAK and RISIS 2, providing data on firm innovation capabilities and STI indicators from the Paris business ecosystem.

Health data and genomicsemerging
1 project

Participation in GenoMed4ALL (2021-2025) on federated learning and multi-omics for haematological diseases marks a new direction into health AI.

Evolution & trajectory

How they've shifted over time

Early focus
EEN services and sensor technologies
Recent focus
Innovation policy and health AI

In the early period (2014-2018), CCI Paris built its H2020 presence around two parallel tracks: EEN innovation management for SMEs and participation in diverse technology projects (microfluidics, medical devices, border security, light pollution awareness). From 2019 onward, the EEN coordination role became more dominant and routine, while new participations shifted toward research policy intelligence (RISIS 2, STI indicators) and digital health (GenoMed4ALL with federated learning). The organization appears to be consolidating its core EEN role while selectively entering data-intensive domains where business ecosystem knowledge adds value.

CCI Paris is moving from broad technology project participation toward data-driven innovation policy and digital health, suggesting future interest in AI applications with clear business or public service relevance.

Collaboration profile

How they like to work

Role: active_partnerReach: European25 countries collaborated

CCI Paris operates in a dual mode: they coordinate their own EEN service delivery projects (5 as coordinator) while joining larger research consortia as a partner or third party (11 projects). With 188 unique partners across 25 countries, they function as a network hub rather than a deep bilateral collaborator — typical for a chamber of commerce that connects many actors. Their third-party roles in RISIS 2 and KNOWMAK suggest they also contribute data and business intelligence without taking on heavy project management responsibilities.

Extensive pan-European network of 188 unique consortium partners across 25 countries, reflecting both their EEN mandate (which spans all EU member states) and diverse thematic project involvement. The geographic spread is broad with no single dominant partner country beyond France.

Why partner with them

What sets them apart

CCI Paris Ile-de-France brings something most research organizations cannot: direct access to the largest regional business ecosystem in France, with institutional relationships spanning tens of thousands of companies. For consortium builders, this means a partner who can provide real-world market validation, SME engagement channels, and dissemination reach that academic or research partners typically lack. Their EEN track record also makes them a credible partner for any project requiring structured innovation management or technology transfer to industry.

Notable projects

Highlights from their portfolio

  • PROTEUS
    Largest single EC contribution (EUR 625,625) for adaptive microfluidic water quality sensing — shows CCI's capacity to participate in serious technical R&D projects.
  • GenoMed4ALL
    Most recent and forward-looking project (2021-2025), applying federated learning and multi-omics to haematological diseases — a significant pivot into health AI.
  • TOPIC2INNO series
    Five consecutive coordination grants (2014-2021) for EEN innovation management services, demonstrating sustained institutional commitment and EC trust in their delivery capacity.
Cross-sector capabilities
digitalhealthmanufacturingsecurity
Analysis note: Funding data is missing for 7 of 16 projects (including all third-party and some coordinator roles), so the EUR 1.9M total likely understates their full involvement. The TOPIC2INNO series projects are service contracts rather than research, which inflates the coordination count relative to actual R&D leadership. Website data was not available for verification.